Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02845440 · ClinicalTrials.gov registry record · NA
Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,165
- Enrollment target
NCT02845440: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02845440 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,165 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (17% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02845440, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,165 participants
- Enrollment target
Study Summary
The overall aim of this study is to test the effect of academic detailing (i.e. provider-level educational intervention focused on evidence-based smoking cessation treatment for those with psychiatric illness) and community health worker (CHW) support on the provision and utilization of standard of care smoking cessation treatment to those with serious mental illness (SMI) and smoking cessation rates for adults with SMI who smoke.
Primary Outcome
Three pairwise comparisons between usual care (TAU), AD+CHW, and AD for number of participants who are abstinent (defined as 7-day point prevalence tobacco abstinence confirmed with an expired CO of 5 ppm or less) at the intervention year 2 assessment. The investigators hypothesize that (1) those who receive AD+CHW will demonstrate higher rates of tobacco abstinence than those who receive TAU, (2) those who receive AD will demonstrate higher rates of tobacco abstinence than those who received TA
Interventions
- OTHER Treatment as Usual (TAU)
- OTHER Community Health Worker
- OTHER Academic Detailing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,165 participants |
| Start Date | 2016-07-14 |
| Est. Completion | 2021-01-12 |
| Phase | NA |
What the finished NCT02845440 record still lists
NCT02845440 is an interventional study that assigns participants to a tested intervention. Its 1,165 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (17% lower).
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT02845440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02845440 about?
NCT02845440 is a clinical study titled "Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness". The overall aim of this study is to test the effect of academic detailing (i.e. provider-level educational intervention focused on evidence-based smoking cessation treatment for those with psychiatric illness) and community health worker (CHW) support on the provision and utilization of standard of ...
What is the current status of trial NCT02845440?
This trial is currently completed. It is a NA study. The enrollment target is 1,165 participants. The study started on 2016-07-14. Estimated completion is 2021-01-12.
What interventions are being tested in trial NCT02845440?
The interventions under investigation include: Treatment as Usual (TAU) (OTHER), Community Health Worker (OTHER), Academic Detailing (OTHER).
Who is sponsoring clinical trial NCT02845440?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02845440's enrollment target sits among peer trials
1,165 91st of 2000 higher than 1,910 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
- NCT07237048 · 1,164 participants · Phase 2
Minocycline in Stroke Study at Maimonides
- NCT06469788 · 1,170 participants · NA
Testimonials and Navigation in Rheumatology
- NCT04577599 · 1,160 participants · NA
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI